{"id":146955,"date":"2023-05-22T04:24:31","date_gmt":"2023-05-22T08:24:31","guid":{"rendered":"https:\/\/44.250.171.167\/?p=146955"},"modified":"2023-05-22T04:24:32","modified_gmt":"2023-05-22T08:24:32","slug":"divis-laboratories-limited-q4-fy23-net-profit-down-by-64","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/divis-laboratories-limited-q4-fy23-net-profit-down-by-64\/","title":{"rendered":"Divi&#8217;s Laboratories Limited Q4 FY23; Net Profit Down By 64%"},"content":{"rendered":"<p>Divi&#8217;s Laboratories Limited reported Total Income for Q4 FY23 of \u20b92,016.92 Crore down from \u20b92,570.83 Crore year on year, a decline of 21.5%. Consolidated Net Profit of \u20b9320.97 Crore, down 64.1% from \u20b9894.64 Crore in the same quarter of the previous year. The Earnings per Share is \u20b912.09, up from \u20b933.70 in the same quarter of the previous year.<\/p>\n\n\n<div style=\"height:25px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"841\" height=\"1024\" src=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/3f4e1bab-acf7-4643-a617-3a323f175bde-841x1024.png\" alt=\"\" class=\"wp-image-146956\" srcset=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/3f4e1bab-acf7-4643-a617-3a323f175bde-841x1024.png 841w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/3f4e1bab-acf7-4643-a617-3a323f175bde-246x300.png 246w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/3f4e1bab-acf7-4643-a617-3a323f175bde-768x935.png 768w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/3f4e1bab-acf7-4643-a617-3a323f175bde-1261x1536.png 1261w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/3f4e1bab-acf7-4643-a617-3a323f175bde-1681x2048.png 1681w\" sizes=\"auto, (max-width: 841px) 100vw, 841px\" \/><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>Divi&#8217;s Laboratories Limited reported Total Income for Q4 FY23 of \u20b92,016.92 Crore down from \u20b92,570.83 Crore year on year, a decline of 21.5%. Consolidated Net Profit of \u20b9320.97 Crore, down 64.1% from \u20b9894.64 Crore in the same quarter of the previous year. The Earnings per Share is \u20b912.09, up from \u20b933.70 in the same quarter [&hellip;]<\/p>\n","protected":false},"author":1917,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[105,392],"tags":[8157],"class_list":["post-146955","post","type-post","status-publish","format-standard","hentry","category-infographics","category-earnings","tag-healthcare"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":133056,"url":"https:\/\/alphastreet.com\/india\/infographic-divis-lab-q1-results-out-net-profit-rises-26\/","url_meta":{"origin":146955,"position":0},"title":"Infographic: Divi&#8217;s Lab Q1 results out, Net profit rises 26%","author":"Chirag Gupta","date":"August 12, 2022","format":false,"excerpt":"On Friday, Pharmaceuticals company Divis Laboratories reported a 26% rise in its consolidated net profit at \u20b9702 crore as compared to \u20b9557 crore in the same quarter last year. Meanwhile, its revenue from operations rose about 15% to \u20b92,254 crore from \u20b91,960.6 crore year-on-year (YoY). Profit before tax (PBT) came\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"trending stocks high volatility","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2020\/02\/Trending-stocks.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2020\/02\/Trending-stocks.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2020\/02\/Trending-stocks.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":145695,"url":"https:\/\/alphastreet.com\/india\/dr-reddys-laboratories-q4-fy23-net-profit-surged-up-to-%e2%82%b9960-crore\/","url_meta":{"origin":146955,"position":1},"title":"Dr Reddy&#8217;s Laboratories Q4 FY23; Net Profit Surged Up To \u20b9960 Crore","author":"Hardik Bhandare","date":"May 10, 2023","format":false,"excerpt":"Dr. Reddy\u2019s Laboratories Limited reported Total Income for Q4 FY23 of \u20b96,453.7 Crore up from \u20b95,596.8 Crore year on year, a growth of 15.3%. Consolidated Net Profit of \u20b9960.1 Crore, surged from \u20b997 Crore in the same quarter of the previous year. The Earnings per Share is \u20b957.68, from \u20b95.83\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/69a8bb46-8f0d-4225-ab06-f2f943aaae93.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/69a8bb46-8f0d-4225-ab06-f2f943aaae93.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/69a8bb46-8f0d-4225-ab06-f2f943aaae93.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/69a8bb46-8f0d-4225-ab06-f2f943aaae93.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/69a8bb46-8f0d-4225-ab06-f2f943aaae93.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/69a8bb46-8f0d-4225-ab06-f2f943aaae93.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":145690,"url":"https:\/\/alphastreet.com\/india\/earnings-summary-of-dr-reddy-s-laboratories-limited-for-q4-fy23\/","url_meta":{"origin":146955,"position":2},"title":"Earnings Summary Of Dr Reddy &#8216;s Laboratories Limited For Q4 FY23","author":"Hardik Bhandare","date":"May 10, 2023","format":false,"excerpt":"Dr. Reddy's Laboratories Limited is an Indian multinational pharmaceutical company with a presence in over 25 countries. It was founded in 1984 and has its headquarters in Hyderabad, India. Dr. Reddy's is a research-driven company with a focus on developing and manufacturing high-quality pharmaceutical products. The company operates in three\u2026","rel":"","context":"In &quot;Earnings&quot;","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-9-1.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-9-1.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-9-1.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-9-1.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-9-1.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-9-1.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":147519,"url":"https:\/\/alphastreet.com\/india\/earnings-summary-of-ipca-laboratories-industries-limited-for-q4-fy23\/","url_meta":{"origin":146955,"position":3},"title":"Earnings Summary Of Ipca Laboratories Industries Limited For Q4 FY23","author":"Hardik Bhandare","date":"May 30, 2023","format":false,"excerpt":"Ipca Laboratories Limited is a leading pharmaceutical company headquartered in Mumbai, India. With over 75 years of experience, the company specializes in the development, manufacture, and marketing of a wide range of pharmaceutical products. Ipca Labs has a strong presence both in the domestic market of India and in several\u2026","rel":"","context":"In &quot;Earnings&quot;","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-6-7.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-6-7.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-6-7.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-6-7.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-6-7.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/898c572d-b97a-4c10-acd3-c5f4d9ad88be-6-7.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":170171,"url":"https:\/\/alphastreet.com\/india\/divis-laboratories-q1-fy26-earnings-results\/","url_meta":{"origin":146955,"position":4},"title":"Divi&#8217;s Laboratories Q1 FY26 Earnings Results","author":"Divyansh_Kasana","date":"August 14, 2025","format":false,"excerpt":"Divi\u2019s Laboratories Limited, incorporated in 1990, is engaged in the manufacture and export of Active Pharmaceutical Ingredients (APIs), intermediates, and nutraceutical ingredients. Presenting below are its Q1 FY26 Earnings Results. Q1 FY26 Earnings Results Revenue: \u20b92,410 crore, up 13.79% year-on-year (YoY) from \u20b92,118 crore in Q1 FY25. Total Expenses: \u20b91,796\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"DIVISLAB Q1 FY26 Earnings Results","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/DILAB.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/DILAB.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/DILAB.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/DILAB.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/DILAB.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/DILAB.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":154152,"url":"https:\/\/alphastreet.com\/india\/divis-laboratories-ltd-q1fy24-49-fall-in-profits\/","url_meta":{"origin":146955,"position":5},"title":"Divi&#8217;s Laboratories Ltd Q1FY24; 49% fall in Profits","author":"Divyansh_Kasana","date":"August 16, 2023","format":false,"excerpt":"Incorporated in 1990, Divis Laboratories Ltd manufactures and exports API's, Intermediates and Nutraceutical ingredients Financial Results: Divi's Laboratories Ltd reported Revenues for Q1FY24 of \u20b91,778.00 Crores down from \u20b92,255.00 Crore year on year, a fall of 21.15%. Total Expenses for Q1FY24 of \u20b91,367.00 Crores down from \u20b91,491.00 Crores year on\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-1149.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-1149.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-1149.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-1149.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-1149.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-1149.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/146955","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1917"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=146955"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/146955\/revisions"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=146955"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=146955"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=146955"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}